ENTITY

Hubei Biocause Pharmaceutical Co (000627 CH)

Analysis

Materials • China

Hubei Biocause Pharmaceutical Co., Ltd. develops and produces pharmaceuticals focusing on the treatment of colonitis, high blood pressure, and infectious diseases. The Company also manufactures and markets carbinol and polypropylene chemical products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00